Aurobindo Pharma shares gained 2% on Monday morning after a US-based unit, Aurolife Pharma, cleared an FDA plant inspection with VAI status. The gain follows...
Shares of Aurobindo Pharma plummeted 5% on 5 February after the pharma major halted production at one unit after USFDA issued 9 observations for its...